← Evidence map

ArticleEuropean journal of hospital pharmacy : science and practice2022

Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy.

Ielizza Desideri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33214132